PATENT CLAIM ANALYSIS

Application Number: 16177159
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "183000"]

Abstract:
Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.

Claim (Index 17):
A stable oral liquid formulation, consisting essentially of:\n (i) about 0.6 to about 1.2 mg/ml enalapril or a pharmaceutically acceptable salt or solvate thereof, (ii) a buffer comprising citric acid and sodium citrate; (iii) a preservative; and (iv) water;\n wherein the formulation is stable at about 5\u00b13\u00b0 C. for at least 12 months; and \n wherein the stable oral liquid formulation has about 95% w/w or greater of the initial enalapril amount and about 5% w/w or less total impurity or related substances at the end of the given storage period.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 97.0
- Lexical Diversity: 1.27586
- Patent Class: 514.0
- Transitional Phrase Type: half
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15081603', '15613622', '16003994', '15802341', '15483691']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8071626312680604
- 35 USC 102 Novelty (BERT): 0.586442801395347
- Combined Prediction Score: 0.7850906482807891
- Mean Citation Score: 455.904018
- Max Citation Score: 484.54633
- Similarity Product: 416.84305088066696

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test